AbbVie’s Latest Results Reveal a Trend Investors Shouldn’t Overlook
AbbVie (ABBV +0.76%) has not performed well this year, but the company’s recent first-quarter update, released on April 29, helped breathe new life into the stock, which jumped by more than 3% post-earnings. Could this be the start of a sustained rally? It’s hard to say. However, AbbVie’s financial results once again highlighted one of […]








